Verrica Pharmaceuticals (VRCA)CEO bought ~$101K

~$101K

Approx. value · 20K sh @ $5.06

203K

Holds after · shares reported

Traded

Aug 14, 2026

Filed

Aug 18, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
2. Aug 14, 2026 · this disclosureInsiderCEO purchased ~$101K of VRCA shares in the open market

What came next

1. Aug 17, 2026Insider · 3 peopleInsiders: 3 purchases (~$75K)
2. Aug 18, 2026Insider · 2 peopleInsiders: 2 purchases (~$35K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Verrica Pharmaceuticals

For Verrica Pharmaceuticals, OQRO holds 6 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VRCA page.

Other recent filings by Jayson Rieger, CEO and President

• SEC Form 4 at Verrica Pharmaceuticals (VRCA)Aug 18, 2026
• SEC Form 4 at Verrica Pharmaceuticals (VRCA)Nov 26, 2025

The full history of Jayson Rieger, CEO and President is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Verrica Pharmaceuticals

• SEC Form 4Aug 18, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 4Nov 26, 2025

Everything OQRO holds on this company is on its VRCA page.